Ken Griffin
SSKN

Ken Griffin’s Strata Skin Sciences SSKN Stock Holding History

Ken Griffin’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-28,841
Closed -$76.1K – 14962
2025
Q1 		$76.1K Sell
28,841
-2,381
-8% -$6.63K ﹤0.01% 11819
2024
Q4 		$90.2K Buy
31,222
+9,370
+43% +$28K ﹤0.01% 11629
2024
Q3 		$60.1K Buy
+21,852
New +$68.3K ﹤0.01% 11700
2023
Q3 		– Sell
-1,225
Closed -$11.6K – 15074
2023
Q2 		$11.6K Buy
+1,225
New +$12.1K ﹤0.01% 13125
2023
Q1 		– Sell
-1,785
Closed -$14.1K – 15479
2022
Q4 		$14.1K Buy
+1,785
New +$15.3K ﹤0.01% 13409
2019
Q2 		– Sell
-1,350
Closed -$38K – 9811
2019
Q1 		$38K Buy
+1,350
New +$41.1K ﹤0.01% 8922
2018
Q4 		– Sell
-1,150
Closed -$41K – 9724
2018
Q3 		$41K Sell
1,150
-1,102
-49% -$27.1K ﹤0.01% 8845
2018
Q2 		$46K Buy
2,252
+64
+3% +$1.04K ﹤0.01% 8453
2018
Q1 		$25K Buy
+2,188
New +$29.2K ﹤0.01% 8089
2017
Q3 		– Sell
-1,408
Closed -$34K – 8027
2017
Q2 		$34K Buy
+1,408
New +$39.2K ﹤0.01% 7178
2017
Q1 		– Sell
-419
Closed -$9K – 8016
2016
Q4 		$9K Buy
419
+100
+31% +$2.56K ﹤0.01% 7156
2016
Q3 		$8K Buy
+319
New +$10.2K ﹤0.01% 7151
2016
Q1 		– Sell
-604
Closed -$34K – 7885
2015
Q4 		$34K Buy
604
+333
+123% +$19K ﹤0.01% 7588
2015
Q3 		$15K Sell
271
-2
-0.7% -$116 ﹤0.01% 8334
2015
Q2 		$16K Buy
+273
New +$22.2K ﹤0.01% 8263
2015
Q1 		– Sell
-291
Closed -$17K – 8828
2014
Q4 		$17K Buy
291
+38
+15% +$3.12K ﹤0.01% 7920
2014
Q3 		$22K Buy
253
+90
+55% +$10.6K ﹤0.01% 7362
2014
Q2 		$26K Buy
+163
New +$36.9K ﹤0.01% 7164
2014
Q1 		– Sell
-37
Closed -$12K – 8002
2013
Q4 		$12K Buy
37
+18
+95% +$6.45K ﹤0.01% 6669
2013
Q3 		$7K Sell
19
-3
-14% -$1.2K ﹤0.01% 6532
2013
Q2 		$10K Buy
+22
New +$11.8K ﹤0.01% 6241

Other funds holding SSKN

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $6.06B AUM 28.9% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
AAM
Azzad Asset Management Falls Church, Virginia $1.13B AUM 38.47% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ken Griffin's SSKN Position: Q2 2025 in Review

Ken Griffin sold out of Strata Skin Sciences (SSKN) in Q2 2025, closing a stake of 28,841 shares — an estimated $76.1K sold.

Ken Griffin first reported a position in SSKN in Q2 2013 and held it in 21 quarters. The position peaked at $90.2K in Q4 2024. 16 funds tracked by Wall St. Rank hold SSKN as of Q2 2025.

  • Ken Griffin reported no remaining Strata Skin Sciences position as of Q2 2025 after selling out during the quarter.
  • Ken Griffin sold 28,841 Strata Skin Sciences shares in Q2 2025, an estimated $76.1K.
  • Ken Griffin first reported a position in Strata Skin Sciences in Q2 2013 and held it in 21 quarters.
  • Ken Griffin's Strata Skin Sciences position peaked at $90.2K in Q4 2024.
  • 16 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.